XRCC5 and colorectal carcinoma: Similarly, XRCC5 KD in CRC cells reversed the DCLK1-B OE-induced global increases in malignancy-related and stemness gene expression (Figure S11F) and the DCLK1-B OE-induced increase in sphere-forming ability (Figure S11G).